Efficacy of the 4CMenB vaccine against gonorrhea among men who have sex with men in Hong Kong: A double-blind randomized placebo-controlled trial. | ClinicLens
The emergence of antimicrobial-resistant gonorrhea among men who have sex with men (MSM) demands new prevention strategies. This study aimed to assess the efficacy of the four-component meningococcal group B (4CMenB) vaccine against gonorrhea among MSM. A prospective, randomized,
Medical Literature · Updated
← Back to articlesIf the embedded page does not load in your browser, open it directly.